BRISTOL MYERS SQUIBB CO (BMY) Factsheet
BRISTOL MYERS SQUIBB CO (BMY) Stock Analysis
Analysis from 10-Q filed 2025-10-30. Data as of Q1 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 11.0%. FCF margin 24.6%. D/E 2.2x. Source: 10-Q filed 2025-10-30.
| Metric | Value | Context |
|---|---|---|
| ROIC | 11.0% | Near cost of capital |
| FCF Margin | 24.6% | Strong cash generation |
| Debt/Equity | 2.2x | Elevated debt |
ROIC 11.0% — Top 25% of sector peers. FCF margin 24.6% — Top 5%.
Explore BRISTOL MYERS SQUIBB CO: Earnings History | Filings | ROIC Analysis
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for BMY: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_changes, get_metric_history, compare_companies, screen_filing_signals.
Profitability: BRISTOL MYERS SQUIBB CO earns 11.0% ROIC, Top 25% in Healthcare
ROIC TTM 11.0%, sector median -2.5%, Top 25%. DuPont: NOPAT margin 15.0% × asset turnover 0.5x. Gross margin 70.5%. Operating margin 19.8%. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 11.0% | Adequate | Above sector median of -2.5% |
| Return on Equity (ROE) | 39.8% | Excellent | Efficient use of shareholder equity |
| Gross Margin | 70.5% | Excellent | Strong pricing power |
| Operating Margin | 19.8% | Good | Efficient operations |
Cash Flow: BRISTOL MYERS SQUIBB CO generates $11.9B FCF at 24.6% margin, positive NaN/8 quarters
FCF TTM $11.9B. FCF margin 24.6%, Top 5%. OCF/Net income 1.8x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 24.6% | Excellent | Excellent cash conversion |
| Free Cash Flow (TTM) | $11.9B | Good | Positive cash generation |
| OCF/Net Income | 1.8x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: BRISTOL MYERS SQUIBB CO at 2.2x leverage
Debt/Equity 2.2x. Total debt $44.5B, cash & investments $10.5B. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Debt to Equity | 2.2x | Warning | Elevated leverage |
| Net Cash Position | $-34.0B | Warning | Net debt position |
Valuation: BRISTOL MYERS SQUIBB CO trades at 17.0x earnings
P/E 17.0x. EV/Sales 3.3x. FCF yield 9.6%. Dividend yield 4.1%. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| P/E Ratio | 17.0x | Adequate | Reasonable valuation |
| EV/Sales | 3.3x | Good | Growth premium priced in |
| FCF Yield | 9.6% | Excellent | Attractive cash return |
| Dividend Yield | 4.1% | Good | Meaningful income |
Capital Allocation: BRISTOL MYERS SQUIBB CO returns 4.1% shareholder yield
Total shareholder yield 4.1% (div 4.1%). Capital returned $5.1B TTM. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 4.1% | Good | Dividend + buyback yield combined |
| Total Capital Returned (TTM) | $5.1B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 11.0% | Top 25% | - |
| Free Cash Flow Margin | 24.6% | Top 5% | - |
| Gross Margin | 70.5% | Top 50% | 1.1x above |
| Operating Margin | 19.8% | Top 25% | 8.6x above |
| Return on Equity (ROE) | 39.8% | Top 25% | - |
| P/E Ratio | 17.0x | N/A | - |
Financial Scorecard
| Metric | BMY | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 11.0% | Adequate | Top 25% of sector (median: -2.5%) |
| Free Cash Flow Margin | 24.6% | Excellent | Top 5% of sector (median: 0.0%) |
| Gross Margin | 70.5% | Excellent | Top 50% of sector (median: 64.7%) |
| Debt to Equity Ratio | 221.5% | Warning | High financial leverage |
| P/E Ratio (Price-to-Earnings) | 17.0x | Adequate | Fair value |
| Free Cash Flow Yield | 9.6% | Excellent | High cash return |
Frequently Asked Questions
Q: What is BRISTOL MYERS SQUIBB CO's Return on Invested Capital (ROIC)?
BRISTOL MYERS SQUIBB CO (BMY) has a trailing twelve-month Return on Invested Capital (ROIC) of 11.0%. Sector median -2.5%. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's Free Cash Flow Margin?
BRISTOL MYERS SQUIBB CO (BMY) has a free cash flow margin of 24.6%, generating $11.9 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's P/E ratio and how does it compare to peers?
BRISTOL MYERS SQUIBB CO (BMY) trades at a P/E ratio of 17.0x, which is above the sector median of N/A. EV/Sales 3.3x. FCF yield 9.6%. Source: 10-Q filed 2025-10-30.
Q: Does BRISTOL MYERS SQUIBB CO pay a dividend?
BRISTOL MYERS SQUIBB CO (BMY) currently pays a dividend yield of 4.1%. Total shareholder yield (dividend + buybacks) 4.1%. Source: 10-Q filed 2025-10-30.
Q: How much debt does BRISTOL MYERS SQUIBB CO have?
BRISTOL MYERS SQUIBB CO (BMY) has a debt-to-equity ratio of 2.2x with total debt of $44.5 billion. Net debt $34.0 billion. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's revenue and earnings growth?
BRISTOL MYERS SQUIBB CO (BMY) grew revenue by 1.8% year-over-year. EPS +33.7% YoY. Source: 10-Q filed 2025-10-30.
Q: How does BRISTOL MYERS SQUIBB CO compare to competitors in Healthcare?
Compared to other companies in Healthcare, BRISTOL MYERS SQUIBB CO (BMY) shows: ROIC 11.0%, sector median -2.5% (Top 25%). FCF margin 24.6%, sector median 0.0% (Top 5%). Gross margin 70.5%, 5.7pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with BRISTOL MYERS SQUIBB CO?
Quantitative warning flags for BRISTOL MYERS SQUIBB CO (BMY): 1) debt/equity 2.2x (above 1.5x threshold). Source: 10-Q filed 2025-10-30.
Data Source: Data sourced from 10-Q filed 2025-10-30. TTM metrics as of Q1 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.